Jean‐Marc Hoffmann

Author

Jean‐Marc Hoffmann

Heidelberg University ORCID

Also Known As

Hoffmann, Jean-Marc, J HOFFMANN, J. Hoffmann, J.‐M. Hoffmann, Jean-Marc Hoffmann, Jean‐Marc Hoffmann

Publications

529

Citations

H-Index

Concepts

All Affiliations

Heidelberg University University Hospital Heidelberg National Center for Tumor Diseases Deutschen Konsortium für Translationale Krebsforschung University Hospital of Zurich

About

Jean‐Marc Hoffmann is an author at Heidelberg University specializing in immunology, cell biology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	108
2	Cell Biology	3	3	108
3	Immunology	3	3	108
4	Cellular Therapies	2	2	58
5	Marrow Transplantation	1	1	38

Jean‐Marc Hoffmann

Publications

386

Citations

H-Index

Page 1

	Year	Citations
Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia Patients Jean‐Marc Hoffmann, Maria‐Luisa Schubert, Lei Wang, Frontiers in Immunology	2018	96
Idelalisib for optimized CD19‐specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients Sophia Stock, Rudolf Übelhart, Maria‐Luisa Schubert, International Journal of Cancer	2019	78
Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells Wenjie Gong, Jean‐Marc Hoffmann, Sophia Stock, Cancer Immunology Immunotherapy InflammationAutoimmune DiseaseT-regulatory CellImmune RegulationImmunology	2019	50
Chimeric Antigen Receptor T Cell Therapy Targeting CD19-Positive Leukemia and Lymphoma in the Context of Stem Cell Transplantation Maria‐Luisa Schubert, Angela Hückelhoven, Jean‐Marc Hoffmann, Human Gene Therapy Lymphoid NeoplasiaCell TherapyTransplantationCar TherapyMalignant Blood Disorder	2016	38
Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic Effects Lei Wang, Ming Ni, Angela Hückelhoven‐Krauss, Frontiers in Immunology	2018	30
Influence of Retronectin-Mediated T-Cell Activation on Expansion and Phenotype of CD19-Specific Chimeric Antigen Receptor T Cells Sophia Stock, Jean‐Marc Hoffmann, Maria‐Luisa Schubert, Human Gene Therapy	2018	24
Tumor-Specific Reactive Oxygen Species Accelerators Improve Chimeric Antigen Receptor T Cell Therapy in B Cell Malignancies Yibin Liu, Lei Wang, Maria‐Luisa Schubert, International Journal of Molecular Sciences Cell TherapyImmunologyImmunoeditingImmune Cell TherapyImmunotherapy	2019	20
Detailed patient-individual reporting of lymph node involvement in oropharyngeal squamous cell carcinoma with an online interface Roman Ludwig, Jean‐Marc Hoffmann, Bertrand Pouymayou, Radiotherapy and Oncology	2022	15
The carbon footprint of clinical trials: a global survey on the status quo and current regulatory guidance Jean‐Marc Hoffmann, Annina Bauer BMJ Global Health	2023	14
Integrating environmental outcomes in randomised clinical trials: a call to action Johanne Juul Petersen, Linn Hemberg, Lehana Thabane, The Lancet	2024	11

Page 1